Market Participants Recognise Almirall, S.A.'s (BME:ALM) Revenues
Apr 24
Spanish (IBEX) Healthcare Sector Analysis
UpdatedApr 26, 2024
DataAggregated Company Financials
Companies14
- 7D0.6%
- 3M-0.2%
- 1Y11.3%
- YTD-18.3%
Over the last 7 days, the Healthcare industry has remained flat, although notably Laboratorios Farmaceuticos Rovi gained 6.6%. As for the the longer term, the industry is up 11% over the past 12 months. As for the next few years, earnings are expected to grow by 27% per annum.
Sector Valuation and Performance
Has the Spanish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Apr 2024 | €13.8b | €10.0b | €297.7m | 17.4x | 46.5x | 1.4x |
| Sun, 24 Mar 2024 | €13.3b | €10.0b | €289.0m | 20.6x | 46.2x | 1.3x |
| Tue, 20 Feb 2024 | €15.1b | €10.0b | €331.9m | 18.4x | 45.5x | 1.5x |
| Thu, 18 Jan 2024 | €13.3b | €10.0b | €332.5m | 17.3x | 39.9x | 1.3x |
| Sat, 16 Dec 2023 | €16.2b | €10.0b | €332.5m | 17x | 48.6x | 1.6x |
| Mon, 13 Nov 2023 | €14.2b | €9.9b | €322.4m | 16.2x | 43.9x | 1.4x |
| Wed, 11 Oct 2023 | €15.0b | €9.8b | €302.1m | 18.2x | 49.5x | 1.5x |
| Fri, 08 Sep 2023 | €15.0b | €9.8b | €311.0m | 19.2x | 48.3x | 1.5x |
| Sun, 06 Aug 2023 | €15.2b | €9.8b | €311.0m | 21.2x | 48.8x | 1.6x |
| Tue, 04 Jul 2023 | €13.6b | €9.6b | €364.5m | 19.3x | 37.3x | 1.4x |
| Thu, 01 Jun 2023 | €13.1b | €9.6b | €366.5m | 20.4x | 35.9x | 1.4x |
| Sat, 29 Apr 2023 | €12.4b | €9.3b | €566.0m | 17.5x | 22x | 1.3x |
| Mon, 27 Mar 2023 | €12.0b | €9.3b | €564.2m | 18.9x | 21.3x | 1.3x |
| Wed, 22 Feb 2023 | €16.1b | €8.4b | €424.4m | 13.4x | 38x | 1.9x |
| Fri, 20 Jan 2023 | €14.4b | €8.4b | €430.6m | 14.1x | 33.5x | 1.7x |
| Sun, 18 Dec 2022 | €13.5b | €8.4b | €430.5m | 14x | 31.3x | 1.6x |
| Tue, 15 Nov 2022 | €13.9b | €8.3b | €460.9m | 14.3x | 30.1x | 1.7x |
| Thu, 13 Oct 2022 | €12.5b | €8.4b | €462.3m | 13.4x | 27.1x | 1.5x |
| Sat, 10 Sep 2022 | €15.3b | €8.3b | €465.4m | 13.7x | 32.9x | 1.8x |
| Mon, 08 Aug 2022 | €16.5b | €8.3b | €465.4m | 14.1x | 35.4x | 2x |
| Wed, 06 Jul 2022 | €19.3b | €7.9b | €514.2m | 13.6x | 37.6x | 2.4x |
| Fri, 03 Jun 2022 | €20.4b | €7.9b | €505.5m | 14.7x | 40.4x | 2.6x |
| Sun, 01 May 2022 | €19.3b | €7.8b | €487.8m | 14.6x | 39.6x | 2.5x |
| Tue, 29 Mar 2022 | €18.7b | €7.8b | €506.8m | 13.8x | 37x | 2.4x |
| Thu, 24 Feb 2022 | €18.4b | €7.9b | €913.0m | 15.6x | 20.2x | 2.3x |
| Sat, 22 Jan 2022 | €19.1b | €7.9b | €932.5m | 17x | 20.4x | 2.4x |
| Mon, 20 Dec 2021 | €19.0b | €7.8b | €931.2m | 16.9x | 20.4x | 2.4x |
| Wed, 17 Nov 2021 | €19.8b | €7.8b | €911.9m | 18.7x | 21.7x | 2.6x |
| Fri, 15 Oct 2021 | €21.7b | €7.8b | €912.6m | 19.3x | 23.8x | 2.8x |
| Sun, 12 Sep 2021 | €22.0b | €7.8b | €912.6m | 18.2x | 24.1x | 2.8x |
| Tue, 10 Aug 2021 | €22.2b | €7.8b | €912.6m | 18.3x | 24.3x | 2.9x |
| Mon, 03 May 2021 | €22.8b | €7.7b | €876.2m | 21.4x | 26.1x | 3x |
Price to Earnings Ratio
26.1x
Current Industry PE
- Investors are optimistic on the Spanish Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 46.5x which is higher than its 3-year average PE of 33.9x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 30% per year over the last three years.
- Meanwhile revenues for these companies have grown 9.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare sector?
| ES Market | 1.75% | |
| Healthcare | 0.62% | |
| Pharma | 5.26% | |
| Medical Equipment | 0.81% | |
| Healthtech | 0% | |
| Healthcare Services | -0.76% | |
| Life Sciences | -3.93% | |
| Biotech | -4.80% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 29.6x.
- Analysts are expecting annual earnings growth of 146.4%, which is higher than its past year's earnings growth of 21.9% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 146% over the next 5 years.
- This is better than its past earnings growth rate of 22% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 21% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ROVI Laboratorios Farmaceuticos Rovi | €84.70 | 6.7% +€274.6m | 110.8% | PE25.8x | |
| ALM Almirall | €8.47 | 2.7% +€47.1m | -9.0% | PS2x | |
| PHM Pharma Mar | €28.82 | 9.8% +€45.5m | -23.5% | PE447.1x | |
| FAE Faes Farma | €3.32 | 4.2% +€42.0m | 3.8% | PE11.2x | |
| ORY Oryzon Genomics | €1.98 | 4.6% +€5.1m | -6.5% | PB1.4x |
